Over 50 million people globally suffer from epilepsy, with seizures risking injury, falls, or worse. We're exploring seizure prediction technologies to help patients take protective steps to reduce impacts or even prevent seizures.

More than 4 in 10 adults have high cholesterol and don’t even know it, significantly raising their risk of irreversible heart disease. We’re running a study to non-invasively detect the presence of high cholesterol in patients and to determine the effects of statin treatment on these patients. We’re nearing the end of this study with promising empirical evidence on the horizon.

Shortness of breath can signal respiratory or cardiovascular issues, complicating diagnosis and delaying treatment. We're developing a solution to quickly identify if dyspnea stems from cardiovascular or pulmonary causes.

Over one million people die from tuberculosis every year due to limited access to testing and treatment. We're developing a real-time, high-yield screening tool in partnership with the Bill & Melinda Gates Foundation.

Mammograms cost the US over $4 billion annually. We're developing an early screening tool to save costs, reduce discomfort and radiation exposure, and overcome challenges such as dense breast tissue.

Despite the risks associated with late-stage diagnoses, only 5% of eligible individuals in the US were screened in 2022. We’re developing a screening tool to help drive early detection and boost survival rates.